From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

BREAKING: Zamaz – could Martin Groak being facing jail for his failure to disclose to the Atlas Put option?

By Tom Winnifrith | Thursday 13 June 2024


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


In yesterday's bombshell expose, I revealed that formerly Standard Listed Zamaz, which became Dispensa (DISP), had entered into a put option agreement with Atlas Capital Markets on 25 August 2022 which it failed to disclose which materially overstated the cash raised in the Prospectus. Making false statements in a Prospectus is both a criminal offence and also exposes Martin Groak to civil liability for any investors who lost money in the Zamaz IPO. As the company is almost certain to go bust soon that could be a material bill.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

VANL

Van Elle Holdings – a Buy?

Thursday »

CCT

Character Group – a Buy?

 

ING

Ingenta – now a Buy again?

 

Clown

Which PR genius wrote this?

 

HAT

H&T Group – now again a Buy

Time left: 00:26:30